FCF Margin % is calculated as Free Cash Flow divided by its Revenue. iBio's Free Cash Flow for the
three
months ended in Mar. 2024 was $-3.65 Mil. iBio's Revenue for the
three
months ended in Mar. 2024 was $0.00 Mil. Therefore, iBio's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.
The historical rank and industry rank for iBio's FCF Margin % or its related term are showing as below:
IBIO'
s FCF Margin % Range Over the Past 10 Years
Min: -38352 Med: -1485.7 Max: -266.88
Current: -38352
During the past 13 years, the highest FCF Margin % of iBio was -266.88%. The lowest was -38352.00%. And the median was -1485.70%.
IBIO's FCF Margin % is ranked worse than 96.35% of 1042
companies
in the Biotechnology industry
Industry Median: -139.2
vs IBIO: -38352.00
iBio FCF Margin % Historical Data
The historical data trend for iBio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, iBio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iBio's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, iBio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where iBio's FCF Margin % falls into.
iBio FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
iBio's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iBio FCF Margin % Related Terms
Thank you for viewing the detailed overview of iBio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IBIO has been successfully added to your 